Experience with selexipag in triple therapy for pulmonary arterial hypertension in Chinese children
Meng Li, Yingchun Wang, Xiaoyu Hu, Haizhao Zhao, Weida Lu, Yuan Ji, Xiaopei CuiQilu Hospital and Cheeloo College of Medicine of Shandong University. China BioMedical Central PediatricsBMC Pediatr 2026; DOI: 10.1186/s12887-026-06954-9 AbstractBackground: Selexipag is an orally effective prostacyclin receptor agonist that has been approved for treating pulmonary arterial hypertension (PAH) in adults but is still used off-label […]
